Milder clinical and biochemical phenotypes associated with the c.482G > A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening
- 1 September 2017
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 122 (1-2) , 60-66
Abstract
No abstract availableKeywords
Funding Information
- NIH (5K08DK106453, R01GM098387)
This publication has 42 references indexed in Scilit:
- Guidelines for diagnosis and management of the cobalamin‐related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiencyJournal of Inherited Metabolic Disease, 2016
- Clinical presentation, gene analysis and outcomes in young patients with early-treated combined methylmalonic acidemia and homocysteinemia (cblC type) in Shandong province, ChinaBrain and Development, 2016
- Ophthalmic Manifestations and Long-Term Visual Outcomes in Patients with Cobalamin C DeficiencyOphthalmology, 2016
- Pathogenic Mutations Differentially Affect the Catalytic Activities of the Human B12-processing Chaperone CblC and Increase Futile Redox CyclingJournal of Biological Chemistry, 2015
- A clinical and gene analysis of late-onset combined methylmalonic aciduria and homocystinuria, cblC type, in ChinaJournal of the Neurological Sciences, 2012
- Cobalamin C defect: natural history, pathophysiology, and treatmentJournal of Inherited Metabolic Disease, 2010
- Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC typeMolecular Genetics and Metabolism, 2008
- Marfanoid features in a child with combined methylmalonic aciduria and homocystinuria (CblC type)Journal of Inherited Metabolic Disease, 2007
- Newborn Screening: Toward a Uniform Screening Panel and System—Executive SummaryPediatrics, 2006
- Adult-onset combined methylmalonic aciduria and homocystinuria (cblC)Neurology, 2001